#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B with anti factor IX Diffuse large B-cell lymphoma recurrent Gaucher's disease type III Postprandial hypoglycaemia Leukaemia Neurodegenerative disorder Mitochondrial DNA depletion Microvillous inclusion disease Metastases to peritoneum Autoimmune demyelinating disease Frontotemporal dementia Pyruvate dehydrogenase complex deficiency Osteopetrosis Congenital ectodermal dysplasia Hodgkin's disease refractory More trials…

    Learn about Rare Diseases

    MELAS syndrome – Trials in Disease Isodicentric chromosome 15 syndrome – Basic Information Toxic epidermal necrolysis – Trials in Disease Carcinoid syndrome – Treatment Ornithine transcarbamoylase deficiency – Trials in Disease Arterial tortuosity syndrome – Trials in Disease Basal cell naevus syndrome Atypical teratoid/rhabdoid tumour of CNS – Basic Information Glomerulonephritis rapidly progressive Ocular melanoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    INSULIN DEGLUDEC Cytarabine Annamycin Repagermanium Olea Europaea Pollen Extract Linezolid Ozanimod Hydrochloride Ranolazine S227928 Zanubrutinib Maribavir Floxuridine Treosulfan Asciminib ASP2957 Insulin Glargine Ipn01194 H2-Receptor Antagonist GSKVX000000070965 Imatinib More therapies…

    Learn about Your Condition

    Genitourinary tract neoplasm Acute hepatic failure Cutaneous T-cell lymphoma Metastatic glioma Addison's disease Glomerulonephritis chronic Eye pain Limb reduction defect Pleomorphic liposarcoma HER2 positive breast cancer Nodular melanoma Head and neck cancer stage IV Alopecia areata Partial seizures Insulin resistance More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Drug level

  • A study to test how BI 1291583 is broken down and removed from the body in healthy men

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Bi 1291583
    The Netherlands
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!